Dynamic Assessment of Right Ventricular Function With Inhaled Nitric Oxide During Cardiac MRI

Completed · Early Phase 1

Conditions studied: Pulmonary Vascular Disorder

In brief

The purpose of the study is to measure RV ejection fraction (RVEF), pulmonary flow, and pulmonary perfusion before and after exposure to inhaled nitric oxide in patients with pulmonary arterial hypertension (PAH) who are known to be vasodilator-responsive based on invasive catheterization as well as healthy subjects. Measurements will also be made after high flow oxygen alone to test the relative vasodilatory effect of oxygen and NO. The investigators hypothesize is that inhaled nitric oxide during cardiac MRI can be used to measure dynamic changes in RV-pulmonary vascular function in patients with vasodilator-responsive PAH.

Key facts

Study ID

NCT02220023

Run by

Vanderbilt University

People needed

17

Starts

2014-07-01

Expected to finish

2017-02-01

Last updated by the study team

2017-02-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients age 18 or older of the Vanderbilt Center for Pulmonary Vascular Disease. Vasodilator-responsive patients will be identified based on prior response to inhaled nitric oxide during invasive right heart catheterization
• Healthy subjects age 18 or older not known to have cardiopulmonary disease

You may not qualify if…

• Standard conventional contraindications for cardiac magnetic resonance (CMR) imaging
• Allergy or contraindication to Magnevist (gadopentetate dimeglumine) contrast
• Concurrent intravenous epoprostenol infusion in whom performance of CMR is cumbersome
• Pregnant women

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.